GSK’s ViiV Healthcare Secures EU Approval for Vocabria Combination Therapy for HIV Treatment in Adolescents -January 31, 2025 at 07:33 am EST

0
GSK’s ViiV Healthcare Secures EU Approval for Vocabria Combination Therapy for HIV Treatment in Adolescents -January 31, 2025 at 07:33 am EST

Market Closed –


London S.E.



11:35:16 2025-01-31 am EST

5-day change 1st Jan Change

1,405.00 GBX

+0.21% Intraday chart for GSK plc +3.58% +4.34%

link

Leave a Reply

Your email address will not be published. Required fields are marked *